Increased proinsulin concentrations and excess risk of coronary heart disease in patients with diabetes and prediabetes.
Yudkin
John S
JS
D017322:Clinical Trials, Phase II as Topic / Q000706:statistics & numerical data; D015897:Comorbidity; D003327:Coronary Disease / Q000097:blood / Q000453:epidemiology*; D016207:Cytokines / Q000502:physiology; D003920:Diabetes Mellitus / Q000097:blood / Q000453:epidemiology*; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011236:Prediabetic State / Q000097:blood / Q000453:epidemiology*; D011384:Proinsulin / Q000097:blood*; D011498:Protein Precursors / Q000097:blood; D012306:Risk; D012307:Risk Factors; D013927:Thrombosis / Q000453:epidemiology / Q000209:etiology
D016207:Cytokines; D011498:Protein Precursors; C070703:proinsulin, des(31,32)-; D011384:Proinsulin